Stability of plasma lactate in vitro in the presence of antiglycolytic agents.
The use of plasma lactate to assess metabolic or circulatory impairment requires definition of critical preanalytical and analytical parameters. Stability has been documented for only 15 min after acquisition when samples were collected with fluoride and transported on ice. We examined time elapsed before analysis, storage temperature, and the antiglycolytic agent used to define preanalytical conditions. Plasma lactate was measured with a Kodak Ektachem 700XR analyzer. In controlled studies on volunteers, storage on ice slowed but did not eliminate the production of lactate; for samples collected with sodium fluoride (F) and potassium oxalate (OX), lactate increased by 0.2 mmol/L after 1 h, then changed little regardless of the storage temperature. For patients' samples collected in F/OX, the mean increase was only 0.15 mmol/L after 24 h. Samples with leukocytosis (neutrophil counts 23 x 10(9)-52 x 10(9)/L) were also stable, with a mean increase of 0.3 mmol/L at 8 h. Use of the antiglycolytic agents F and OX (at 60 and 12 mmol/L, respectively) maintained apparently stable lactate concentrations at room temperature for up to 8 h without special handling.
Department of Pathology, Duke University Medical Center, Durham, NC 27710.
R
R
Astles
C P
CP
Williams
F
F
Sedor
D000140:Acidosis, Lactic / Q000097:blood*; D001800:Blood Specimen Collection / Q000379:methods; D004355:Drug Stability; D006019:Glycolysis / Q000187:drug effects*; D006801:Humans; D007773:Lactates / Q000097:blood*; D019344:Lactic Acid; D010070:Oxalates / Q000494:pharmacology; D012969:Sodium Fluoride / Q000494:pharmacology*
D007773:Lactates; D010070:Oxalates; D019344:Lactic Acid; D012969:Sodium Fluoride